<DOC>
	<DOCNO>NCT02081807</DOCNO>
	<brief_summary>This cohort study sequential expansion comparative effectiveness study oral anticoagulant plan identify initiator oral anticoagulant use electronic claim data commercial insurance database quantify association anticoagulant choice ( warfarin dabigatran ) occurrence select outcomes patient non-valvular atrial fibrillation risk stroke .</brief_summary>
	<brief_title>Sequential Expansion Comparative Effectiveness Anticoagulants</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Inclusion criterion : A recorded diagnosis atrial fibrillation . Initiation anticoagulant medication ( dabigatran ( new oral anticoagulant become available ) warfarin ) . At least 18 year age date anticoagulant initiation . CHA2DS2VASc score least 1 Exclusion criterion : Patients miss ambiguous age sex information . Patients evidence valvular disease . Patients less 12 month enrolment precede date anticoagulant initiation Patients dispense oral anticoagulant 12 month precede date anticoagulant initiation Patients nursing home stay 12 month precede date anticoagulant initiation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>